Lung cancer expert Dr. Joseph Leach provides an overview of how
lung cancers with
EGFR mutations are
treated. The good news is that specific treatments can target EGFR mutations. Dr. Leach talks about
targeted therapies including osimertinib (for exon 19 and exon 21 mutations), amivantamab (for an exon 20 insertion mutation), and others. He also discusses chemotherapy. Cancer cells with EGFR mutations can become resistant to treatment, so it is important to
repeat biomarker testing if treatment stops working at any time. A different drug can make treatment more effective again.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.